Page 311«..1020..310311312313..320330..»

RD Fund Appoints Tony Adamis, MD to Board of Directors – Johnson City Press (subscription)

Posted: Published on October 5th, 2021

RALEIGH, N.C., Oct. 4, 2021 /PRNewswire/ -- Today, the Retinal Degeneration Fund(RD Fund) the venture arm of the Foundation Fighting Blindnessand leading investor in the inherited retinal disease space announced the appointment of Anthony (Tony) Adamis, MD, to its board of directors Continue reading →

Posted in Vascular Biology | Comments Off on RD Fund Appoints Tony Adamis, MD to Board of Directors – Johnson City Press (subscription)

Keros Therapeutics Presents Results from a Preclinical Study of RKER-012 in Pulmonary Arterial Hypertension-Associated Bone Loss at the American…

Posted: Published on October 5th, 2021

LEXINGTON, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Keros) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that it presented results from a preclinical study of KER-012 at the American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting held October 1 through 4, 2021 Continue reading →

Posted in Vascular Biology | Comments Off on Keros Therapeutics Presents Results from a Preclinical Study of RKER-012 in Pulmonary Arterial Hypertension-Associated Bone Loss at the American…

Vascular Biogenics : VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United…

Posted: Published on October 5th, 2021

TEL AVIV, Israel and NEW YORK, Oct. Continue reading →

Posted in Vascular Biology | Comments Off on Vascular Biogenics : VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United…

Castle Creek Biosciences Expands its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders through Research Collaboration with…

Posted: Published on October 5th, 2021

EXTON, Pa., Sept. 29, 2021 /PRNewswire/ --Castle Creek Biosciences, Inc., a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options, today announced a research collaboration with Mayo Clinic to advance discovery and pre-clinical development of investigational gene therapy candidates for the treatment of osteogenesis imperfecta (OI) and classical Ehlers-Danlos syndrome (EDS), which are rare genetic connective tissue disorders that currently have no treatments approved by the U.S. Food & Drug Administration (FDA) Continue reading →

Posted in Vascular Biology | Comments Off on Castle Creek Biosciences Expands its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders through Research Collaboration with…

Secondary-Progressive MS (SPMS): Symptoms and Treatment

Posted: Published on October 5th, 2021

Secondary-progressive multiple sclerosis (SPMS) is a form of multiple sclerosis. Its considered the next stage after relapsing-remitting MS (RRMS). With SPMS, there are no longer any signs of remission Continue reading →

Posted in MS Treatment | Comments Off on Secondary-Progressive MS (SPMS): Symptoms and Treatment

Behavioral Health Hospital | Gulfport, MS

Posted: Published on October 5th, 2021

Gulfport Behavioral Health System Our facility provides inpatient treatment options for children, adolescents and adults in need. Medication Management and Transcranial Magnetic Stimulation are available on an outpatient basis for adults. Patients at Gulfport Behavioral are offered a variety of group therapy topics through our treatment programs Continue reading →

Posted in MS Treatment | Comments Off on Behavioral Health Hospital | Gulfport, MS

OCREVUS (ocrelizumab) | Multiple Sclerosis (MS) Treatment

Posted: Published on October 5th, 2021

Who should not receive OCREVUS? Do notreceive OCREVUS if you have an active hepatitis B virus (HBV) infection Continue reading →

Posted in MS Treatment | Comments Off on OCREVUS (ocrelizumab) | Multiple Sclerosis (MS) Treatment

Alternative Therapies That Have Helped Me Manage Different MS Symptoms – WebMD

Posted: Published on October 5th, 2021

Multiple sclerosis is often called the disease of a thousand faces. And thats because the symptoms are variable and can be different for each person. Besides the commonly recommended physical therapy and occupational therapy, theres also a variety of alternative therapies that can help manage your symptoms as well. Continue reading →

Posted in MS Treatment | Comments Off on Alternative Therapies That Have Helped Me Manage Different MS Symptoms – WebMD

Husband of wife who sued to demand ivermectin treatment has died of Covid-19 – The Independent

Posted: Published on October 5th, 2021

Jeffrey Smith, the Covid-19 patient whose wife sued to treat him with the horse medicine ivermectin, has died after a long battle with the virus. According to multiple reports, Mr Smith died in an intensive care unit on 25 September. Mr Smith had been diagnosed with Covid-19 on 9 July, and was hospitalized six days later Continue reading →

Posted in MS Treatment | Comments Off on Husband of wife who sued to demand ivermectin treatment has died of Covid-19 – The Independent

Chronic UTI sufferer, 23, tells how 5-year battle to find treatment left her housebound and needing morphine – iNews

Posted: Published on October 5th, 2021

It took Lexi Kelly-Hunt five and a half years to get a diagnosis for Chronic UTI. Continue reading →

Posted in MS Treatment | Comments Off on Chronic UTI sufferer, 23, tells how 5-year battle to find treatment left her housebound and needing morphine – iNews

Page 311«..1020..310311312313..320330..»